Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer

NCT03340376 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Atezolizumab
DRUG: Doxorubicin

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]